Advertisement

Topics

Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China

11:20 EST 7 Dec 2018 | Investing News Network

Oxford Immunotec Global (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell Selectkit by the China Food and Drug Administration (CFDA). As quoted in the press release: The T-Cell Select kit was designed as an immune cell separation reagent kit to simplify workflow, improve throughput, and reduce hands-on time and labor … Continued

The post Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China appeared first on Investing News Network.

Original Article: Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China

NEXT ARTICLE

More From BioPortfolio on "Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China"

Advertisement
Quick Search
Advertisement
Advertisement